ClinicalTrials.gg
Sign In
CompletedNCT02184728Updated Mar 25, 2015

Comparison of End-tidal Carbon Dioxide (ETCO2) Measured by Transportable Capnometer (EMMATM) and the Arterial pCO2 in General Anesthesia

An interventional study of End-tidal CO2(portable capnometer) in End Tidal Carbon Dioxide of Patients Undergoing General Anesthesia, sponsored by Inje University. Completed at 1 site in South Korea. Open to participants aged 20 Years to 85 Years. Per ClinicalTrials.gov, last updated 2015-03-25.

Sponsored by Inje University · Not applicable and Interventional

Phase
Not applicable
Study type
Interventional
Enrollment
35
Allocation
Not applicable
Ages
20 Years to 85 Years
Sex
All
01

Study summary

An end-tidal CO 2 monitor (capnometer) is used most often as a noninvasive substitute for PaCO2 in anesthesia, anesthetic recovery and intensive care. There is now also wide-spread use of capnometry on-site at emergency and trauma fields. So, portable device can be used usefully.

02

Conditions studied

  • End Tidal Carbon Dioxide of Patients Undergoing General Anesthesia

Keywords

  • end-tidal CO2
  • capnometer
03

In context

Lead sponsor

Inje University is the lead sponsor of 93 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • patients who anticipated arterial gas analyze intraoperatively

Exclusion criteria

Exclusion Criteria:

  • patients who didn't get arterial line
05

Study design

Phase
Not applicable
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
35 participants (actual)

Study arms

  • No intervention
    EMMA(TM)

    A small capnograph for measuring ET-CO2 - the EMMA capnometer 1

    Device: End-tidal CO2(portable capnometer)

Interventions

  • DeviceEnd-tidal CO2(portable capnometer)

    End-tidal CO2(portable capnometer: EMMATM, Side stream capnometry module:Datex-Ohmeda S5 Anesthesia Monitor )levels were recorded at the time of arterial blood gas sampling.

    Also known as: EMMA(TM )

06

What researchers measure

Primary outcomes

  1. End-tidal CO2

    End-tidal CO2(portable capnometer: EMMATM, Side stream capnometry module:Datex-Ohmeda S5 Anesthesia Monitor )levels were recorded at the time of arterial blood gas sampling.

    Time frame: During operation (2-4 times)

07

Study locations

1 site
  • Inje University Seoul Paik Hospital, Seoul, Korea
    Seoul, Jung-Gu, 100-032, South Korea
08

References and documents

Publications

  • Kim KW, Choi HR, Bang SR, Lee JW. Comparison of end-tidal CO2 measured by transportable capnometer (EMMA capnograph) and arterial pCO2 in general anesthesia. J Clin Monit Comput. 2016 Oct;30(5):737-41. doi: 10.1007/s10877-015-9748-x. Epub 2015 Aug 12. PubMed 26264607 ↗
09

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Jun 2014, a primary completion of Jan 2015 and a completion of Mar 2015. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 3, 2014
First posted
Jul 9, 2014
Start
Jun 2014
Primary completionActual
Jan 2015
CompletionActual
Mar 2015
Last update
Mar 25, 2015
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 25, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02184728
Lead sponsor
Inje University
Responsible party
Sira Bang (Assistant Professor, Inje University) — Principal investigator
First posted
Jul 9, 2014
Start date
Jun 2014
Primary completion
Jan 2015
Completion
Mar 2015
Last update
Mar 25, 2015

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2015. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies from this sponsor

Inje University

Start the discussion